ASCEND researchers are partnering with families of children who receive extracorporeal membrane oxygenation (ECMO) after a sudden failure of breathing named pediatric acute respiratory distress syndrome (PARDS). ECMO is a life support technology that uses an artificial lung outside of the body to do the lung's work. ASCEND has two objectives. The first objective is to learn more about children's abilities and quality of life among ECMO-supported children in the year after they leave the pediatric intensive care unit. The second objective is to compare short and long-term patient outcomes in two groups of children: one group managed with a mechanical ventilation protocol that reserves the use of extracorporeal membrane oxygenation (ECMO) until protocol failure to another group supported on ECMO per usual care.
Age range
14 Days – 20 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change in functional status
Timeframe: baseline and 1 year after pediatric intensive care unit discharge
Change in health-related quality of life
Timeframe: baseline and 1 year after pediatric intensive care unit discharge
The proportion of children with a new morbidity
Timeframe: baseline and 1 year after pediatric intensive care unit discharge
All-cause mortality at hospital discharge or 90-days
Timeframe: 90 days after the day of illness on which patients from the two cohorts are matched
Comparative change in one-year functional status
Timeframe: baseline and 1 year after pediatric intensive care unit discharge
Comparative change in one-year health-related quality of life
Timeframe: baseline and 1 year after pediatric intensive care unit discharge